Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

NCT01866449 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme (GBM) WHO Grade IV

Interventions

DRUG: Cabazitaxel

Sponsor

University of Ulm